Solvotrin Therapeutics Logo
  • Home
  • About Us
    • About Solvotrin Therapeutics
    • Research & Development
    • Team
  • Products
  • Contact
    • Connect with Solvotrin
    • Careers
  • News
  • Menu
ASPIRIN BREAKTHROUGH - Trinity scientists retain the power of humble pill while getting rid of the side effects

New Life for an Old Drug (Tech-Nation)

Posted on 28th September 20108th August 2016 by AdminSolv

Dr. Moira Gunn, of Tech-Nation, talks with Mark Ledwidge and John Gilmer, from Solvotrin Therapeutics, about how they’re finding new uses for Aspirin. 19 minutes, 8.8mb, recorded 2010-09-28…Click to Listen

Post navigation

← Cork Pharma Company poised to…
Merck to market: Life science… →

Recent Posts

  • Solvotrin Therapeutics: Improving the tolerance and effectiveness of iron and aspirin
  • Solvotrin take final step to bring Active Iron to China
  • Solvotrin Therapeutics and Roha APD new partnership poised to invigorate German oral iron market
  • Solvotrin Therapeutics and Amophar to bring Active Iron to 3 new European markets
  • Trinity Pharmacy School Prize Giving and Industry Networking Event December 2018

Archives

  • September 2019
  • June 2019
  • December 2018
  • November 2018
  • July 2018
  • September 2016
  • October 2014
  • October 2012
  • November 2011
  • March 2011
  • January 2011
  • October 2010
  • September 2010
  • June 2010
  • May 2010
  • March 2010

Categories

  • News
Contact Location Linkedin

Solvotrin Therapeutics

Head Office,
Hoffmann Park,
Little Island,
Cork, Co. Cork

Telephone: +353 21 4510220
Fax: +353 21 4510229
Email: info@solvotrin.com

  • About Solvotrin Therapeutics
  • Solvotrin Therapeutics Team
  • Research & Development
  • Solvotrin Products
  • Home
  • Contact Us
  • Privacy Policy
  • Location

© 2022 Solvotrin Therapeutics. All Rights Reserved.